| Issue Date | Title | Author(s) |
| 2016 | Correction of ischemic damage to the retina on application of pharmacological preconditioning of recombinant erythropoietin | Shabelnikova, A. S. |
| 2020 | Eleven-amino acid peptides that mimic the erythropoietin α-helix B increases cell survival in endotheliocyte culture | Antsiferov, O. V.; Korokin, M. V.; Gureev, V. V.; Pokrovskii, M. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G. |
| 2020 | Endothelial protective properties of short-chain peptides that mimic α-helix B of erythropoietin in experimental preeclampsia | Golubev, I. V.; Gureev, V. V.; Korokin, M. V.; Gureeva, A. V.; Polyanskaya, A. V.; Pokrovskii, M. V.; Lazareva, G. A.; Bystrova, N. A. |
| 2022 | EPOR/CD131-mediated attenuation of rotenone-induced retinal degeneration is associated with upregulation of autophagy genes | Soldatov, V. O.; Pokrovsky, M. V.; Puchenkova, O. A.; Zhunusov, N. S.; Krayushkina, A. M.; Grechina, A. V.; Soldatova, M. O.; Lapin, K. N.; Bushueva, O. Yu. |
| 2020 | Erythropoietin mimetic peptide (pHBSP) corrects endothelial dysfunction in a rat model of preeclampsia | Korokin, M.; Gureev, V.; Gudyrev, O.; Golubev, I.; Korokina, L.; Peresypkina, A.; Pokrovskaia, T. |
| 2018 | Evaluation of carbamylated darbepoetin acute toxicity | Kolesnichenko, P. D.; Gudyrev, O. S.; Zhuchenko, M. A.; Zhernakova, N. I.; Faitelson, A. V. |
| 2020 | Non-hematopoietic erythropoietin-derived peptides for atheroprotection and treatment of cardiovascular diseases | Belyaeva, V. S.; Stepenko, Yu. V.; Kulikov, A. L.; Kochkarova, I. S.; Martynova, O. V.; Pokrovskiy, M. V. |
| 2018 | Pharmacological correction of retinal ischemia/reperfusion by minoxidil | Peresypkina, A. A.; Gubareva, V. O.; Levkova, E. A.; Shabelnikova, A. S.; Pokrovskii, M. V. |
| 2018 | Pharmacological correction of retinal ischemia/reperfusion by minoxidil | Peresypkina, A. A.; Gubareva, V. O.; Levkova, E. A.; Shabelnikova, A. S.; Pokrovskii, M. V. |
| 2019 | Pharmacological modulation of cell functional activity with valproic acid and erythropoietin | Golubinskaya, P. A.; Sarycheva, M. V.; Burda, S. Y.; Puzanov, M. V.; Nadezhdina, N. A. |
| 2016 | Pharmacological preconditioning by recombinant erythropoietin as the possibility of increasing the stability of tissue of the retina to reperfusion ischemia in experiment | Shabelnikova, A. S.; Peresypkina, A. A.; Gubareva, V. O.; Levkova, E. A.; Dolzhikov, A. A. |
| 2019 | Pleiotropic effects of erythropoietin. Influence of erythropoietin on processes of mesenchymal stem cells differentiation | Zubareva, E. V.; Nadezhdin, S. V.; Burda, Y. E.; Nadezhdina, N. A.; Gashevskaya, A. S. |
| 2017 | Search of new pharmaceuticals on the basis of darbepoetin in the treatment of ischemic stroke: review of literature | Reznikov, K. M.; Gorbunova, N. S.; Kolesnichenko, P. D.; Tverskoy, A. V.; Kostina, D. A. |
| 2022 | Study of the anti-inflammatory and immunotropic activity of the secretome from multipotent mesenchymal stromal cells induced by erythropoietin, valproic acid or dexamethasone in vitro | Golubinskaya, P. A.; Puzanov, M. V.; Sarycheva, M. V.; Burda, S. Yu.; Nadezhdin, S. V.; Korokin, M. V. |
| 2020 | The anti-aggregation activity of new 11-amino acid of erythropoietin derivate containing tripeptide motifs | Golubev, I. V.; Gureev, V. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G.; Pokopeiko, O. N. |
